Scientific and practical approaches in developing process model for the commercialization of intellectual property in pharmacy

E. V. Litvinova, O. V. Posylkina

Abstract


Protection of intellectual property is the prerequisite for the introduction of innovations, reducing innovation risks, as well as financing R&D of drug development.

Aim. To analyze and systematize existing scientific approaches and mechanisms of commercialization of intellectual property in pharmacy for building a process model of this activity.

Materials and methods. We used such methods as: systematization of basic research directions that accompany the life cycle of medicine; cognitive method; systematic approach based on retrospective method and system logic analysis; method of Integration Definition for Function Modeling – IDEF0 (process model for the commercialization of intellectual property in pharmacy).

Results. We presented methodological and methodical approaches of patent protection and commercialization of intellectual property during the drug life cycle and it has proposed process model of commercialization of intellectual property in pharmacy, the main subprocesses of which are “Search for new idea drugs”, commercialization of intellectual property at the stage of “Pharmaceutical development, preclinical, clinical research”, “Technology  transfer”, “Commercial manufacturing, introduction of new drugs into the market”.

Conclusions. Thus, the regulation of the commercialization process and the use of various mechanisms for the commercialization of intellectual property in pharmacy will allow companies to achieve undoubted competitive advantages that ensure the implementation of developer’s property rights, as well as commercial advantages for continuing innovation activities, and medical and pharmaceutical institutions and scientific institutions of National Academy of Medical Sciences provide additional financial resources needed for further scientific research.


Keywords


process model of commercialization; objects of intellectual property pharmacy; drug

References


Karytinos, A., Ingham, A. (2015). A growing interest for intellectual property in universities. Pharmaceutical

Patent Analyst, 4 (2), 59–61. doi: 10.4155/ppa.14.57

McDevitt, V. L., Mendez–Hinds, J., Winwood, D., Nijhawan, V., Sherer, T., Ritter, J. F., Sanberg, P. R. (2014). More than money: the exponential impact of academic technology transfer. Technology & Innovation, 16 (1), 75–84. doi: 10.3727/194982414x13971392823479

Farmatsiia XXI stolittia : tendentsii ta perspektyvy (2016). Kharkiv: NUPh 1, 458.

Timaniuk, V. N. (2007). Upravlinnia protsesamy komertsializatsii intelektualnoi vlasnosti u farmatsevtychnii haluzi. Kharkiv: NUPh, 21.

Nastanova 42–3.0:2011. Likarski zasoby. Farmatsevtychna rozrobka (ICH Q8). Available at: http://www.koleso–to.narod.ru/quolity/farmrazrab.pdf

Nastanova ST–N MOZU 42–4.2:2011. Likarski zasoby. Upravlinnia ryzykamy dlia yakosti (ICH Q9). Available at: http://www.gmpua.com/World/Ukraine/nastanova42422011.pdf

Nastanova ST–N MOZU 42–4.3:2011. Likarski zasoby. Farmatsevtychna systema yakosti (ICH Q10) Available at: http://www.gmpua.com/World/Ukraine/nastanova42432011.pdf

Apteka (2017). Available at: http://www.apteka.ua/article/403592

Liapunov, N. A., Bezugla, E. P. (2013). Farmatcevticheskaia otrasl, 1 (36), 79–86.


GOST Style Citations


1. Karytinos, A. A growing interest for intellectual property in universities / A. Karytinos, A. Ingham // Phar. Pat. Anal. – 2015. – Vol. 4, Issue 2. – P. 59–61. doi: 10.4155/ppa.14.57

2. More than money : the exponential impact of academic technology transfer / V. L. McDevitt, J. Mendez–Hinds, D. Winwood et al. // Technol. Innov. – 2014. – Vol. 16, Issue 1. – P. 75–84. doi: 10.3727/194982414x13971392823479

3. Фармація ХХІ століття : тенденції та перспективи : матер. VIII з’їзду фармацевтів України : у 2–х т., м. Харків, 13–16 верес. 2016 р. – Х. : НФаУ, 2016. – Т. 1. – 458 с.

4. Тіманюк, В. М. Управління процесами комерціалізації інтелектуальної власності у фармацевтичній галузі : автореф. дис ... канд. фармац. наук: 15.00.01. – Х., 2007. – 21 с.

5. Лікарські засоби. Фармацевтична розробка (ICH Q8) : настанова 42 3.0:2011. – Режим доступу : http://www.koleso–to.narod.ru/quolity/farmrazrab.pdf

6. Лікарські засоби. Управління ризиками для якості (ICH Q9) : настанова СТ–Н МОЗУ 42–4.2:2011. – Режим доступу : http://www.gmpua.com/World/Ukraine/nastanova42422011.pdf

7. Лікарські засоби. Фармацевтична система якості (ICH Q10) : настанова СТ–Н МОЗУ 42–4.3:2011. – Режим доступу : http://www.gmpua.com/World/Ukraine/nastanova42432011.pdf

8. Рахункова палата виявила недоліки в організації наукової діяльності НАМН // Аптека. – 2017. – Режим доступу: http://www.apteka.ua/article/403592

9. Ляпунов, Н. А. Современная методология фармацевтической разработки лекарственных препаратов / Н. А. Ляпунов, Е. П. Безуглая // Фармацевтическая отрасль. – 2013. – № 1 (36). – С. 79–86.





DOI: https://doi.org/10.24959/uekj.17.14

Abbreviated key title: Upr. ekon. zabezp. âkostì farm.

ISSN 2519-8807 (Online), ISSN 2311-1127 (Print)